Merck & Co., Inc. (MRK)
147.76
-0.59
(-0.40%)
USD |
NYSE |
Aug 31, 16:00
148.45
+0.69
(+0.47%)
Pre-Market: 06:46
Merck Net Income (TTM) : 3.169B for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.169B |
| March 31, 2026 | 8.934B |
| December 31, 2025 | 18.26B |
| September 30, 2025 | 19.04B |
| June 30, 2025 | 16.42B |
| March 31, 2025 | 17.45B |
| December 31, 2024 | 17.13B |
| September 30, 2024 | 12.16B |
| June 30, 2024 | 13.75B |
| March 31, 2024 | 2.32B |
| December 31, 2023 | 378.00M |
| September 30, 2023 | 4.621B |
| June 30, 2023 | 3.124B |
| March 31, 2023 | 13.04B |
| December 31, 2022 | 14.53B |
| September 30, 2022 | 15.33B |
| June 30, 2022 | 16.65B |
| March 31, 2022 | 13.92B |
| December 31, 2021 | 12.36B |
| September 30, 2021 | 5.92B |
| June 30, 2021 | 3.675B |
| March 31, 2021 | 4.806B |
| December 31, 2020 | 5.276B |
| September 30, 2020 | 10.25B |
| June 30, 2020 | 9.835B |
| Date | Value |
|---|---|
| March 31, 2020 | 10.13B |
| December 31, 2019 | 9.777B |
| September 30, 2019 | 9.191B |
| June 30, 2019 | 9.242B |
| March 31, 2019 | 8.314B |
| December 31, 2018 | 6.193B |
| September 30, 2018 | 3.377B |
| June 30, 2018 | 1.368B |
| March 31, 2018 | 1.603B |
| December 31, 2017 | 2.418B |
| September 30, 2017 | 2.869B |
| June 30, 2017 | 5.108B |
| March 31, 2017 | 4.366B |
| December 31, 2016 | 3.94B |
| September 30, 2016 | 5.508B |
| June 30, 2016 | 5.151B |
| March 31, 2016 | 4.63B |
| December 31, 2015 | 4.458B |
| September 30, 2015 | 10.80B |
| June 30, 2015 | 9.815B |
| March 31, 2015 | 11.16B |
| December 31, 2014 | 11.93B |
| September 30, 2014 | 5.421B |
| June 30, 2014 | 5.729B |
| March 31, 2014 | 4.631B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Johnson & Johnson | 21.04B |
| Eli Lilly & Co. | 26.71B |
| Pfizer Inc. | 4.373B |
| Bristol Myers Squibb Co. | 9.275B |
| Abbott Laboratories | 5.405B |